(b)(6).Prismaflex st100 set c has been temporarily approved for use in the us under emergency use authorization (b)(4) to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.H10: the actual sample was not available; however, a photograph of the sample was provided for evaluation.Visual inspection revealed that the return line was cut.The reported leak is due to the observed line perforation.The reported condition was verified.The exact cause of the condition could not be determined; however, potential causes identified are: transportation issue: a mechanical shock was applied on the product during transport, leading to its damage.Product handling issue: improper handling of the product during/after unpacking, leading to its damage.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|
It was reported that during priming, one unit of prismaflex st100 set c had an external fluid leakage due to a damaged cut slice problem in the tube.After inspection, it was found that there was a gap in the tube causing leakage.There was no patient involvement associated with the reported event.No additional information is available.
|